Atricure Inc. buy stratec
Start price
12.04.19
/
50%
€25.43
Target price
04.11.21
€66.00
Performance (%)
15.17%
End price
05.11.21
€29.29
Summary
This prediction ended on 05.11.21 with a price of €29.29. The prediction had a final performance of 15.17%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atricure Inc. | -0.820% | -0.820% | -60.968% | -60.968% |
| iShares Core DAX® | -0.843% | 3.002% | 2.841% | 49.162% |
| iShares Nasdaq 100 | 1.510% | 13.493% | 33.438% | 102.748% |
| iShares Nikkei 225® | -0.062% | 11.462% | 41.789% | 67.835% |
| iShares S&P 500 | 0.648% | 8.040% | 23.767% | 72.730% |
Comments by stratec for this prediction
In the thread Atricure Inc. diskutieren
stratec stimmt dem Sentiment von 'Sell' nicht zu
The stock got an Overweight rating with a $37 price target at JP Morgan. Morgan's analyst list three key reasons he likes the shares at current trading levels.
- The valuation is attractive and the name offers durable organic mid-teens top-line growth.
- Has a favorable view on the lack of competitors.
- Sees catalysts from COVERAGE data over the coming 1-year period.
Kursziel geändert auf 46,0
Kursziel geändert auf 66,0
In the thread Trading Atricure Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten